We are live on
!
Find out more
SCM
Shelton Capital Management Portfolio holdings
AUM
$4.57B
1-Year Est. Return
32.26%
This Fund
S&P 500
This Quarter
Est. Return
+10.16%
1 Year Est. Return
+32.26%
3 Year Est. Return
+110.31%
5 Year Est. Return
+153.06%
10 Year Est. Return
+630.09%
AUM
$661M
AUM Growth
+$63.6M
(+11%)
Cap. Flow
+$8.57M
Cap. Flow
% of AUM
1.3%
Top 10 Holdings %
Top 10 Hldgs %
16.59%
Holding
777
New
87
Increased
152
Reduced
160
Closed
27
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Axos Financial
AX
|
+$1.14M |
| 2 |
Intercontinental Exchange
ICE
|
+$1.1M |
| 3 |
Exelixis
EXEL
|
+$1.1M |
| 4 |
Tesla
TSLA
|
+$1.09M |
| 5 |
Intel
INTC
|
+$582K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioMarin Pharmaceuticals
BMRN
|
+$3.57M |
| 2 |
FLG
Flagstar Bank National Association
FLG
|
+$1.62M |
| 3 |
CELG
Celgene Corp
CELG
|
+$1.59M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
+$1.54M |
| 5 |
Ametek
AME
|
+$1.25M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.89% |
| 2 | Healthcare | 15% |
| 3 | Financials | 12.41% |
| 4 | Industrials | 10.23% |
| 5 | Energy | 8.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
TSMC
TSM
$2.23T
| $523K | 0.08% |
30,000
| – | – |
|
|
CNQR
302
DELISTED
CONCUR TECHNOLOGIES INC
CNQR
| $523K | 0.08% |
5,070
| – | – |
|
|
AGN
303
DELISTED
Allergan Inc
AGN
| $523K | 0.08% |
4,712
+2,500
| +113% | +$239K |
|
304
Gentex
GNTX
$4.93B
| $521K | 0.08% |
31,580
-886
| -3% | -$13K |
|
305
Seagate
STX
$199B
| $520K | 0.08% |
9,266
+265
| +3% | +$13.1K |
|
306
Acuity Brands
AYI
$10.8B
| $519K | 0.08% |
4,744
| – | – |
|
307
Terex
TEX
$7.8B
| $519K | 0.08% |
12,371
| – | – |
|
308
KBR
KBR
$4.8B
| $517K | 0.08% |
16,199
-479
| -3% | -$15.9K |
|
309
Broadridge
BR
$19.3B
| $515K | 0.08% |
13,033
-499
| -4% | -$18K |
|
|
SIVB
310
DELISTED
SVB Financial Group
SIVB
| $515K | 0.08% |
4,916
| – | – |
|
311
Martin Marietta Materials
MLM
$32.7B
| $514K | 0.08% |
5,140
| – | – |
|
312
Wynn Resorts
WYNN
$10.6B
| $508K | 0.08% |
2,614
+85
| +3% | +$14.5K |
|
|
DRC
313
DELISTED
DRESSER-RAND GROUP INC
DRC
| $508K | 0.08% |
8,514
| – | – |
|
|
HCC
314
DELISTED
HCC INSURANCES HOLDINGS INC
HCC
| $506K | 0.08% |
10,957
-367
| -3% | -$16.6K |
|
315
Valero Energy
VLO
$95.1B
| $505K | 0.08% |
10,022
-5,296
| -35% | -$223K |
|
316
Cboe Global Markets
CBOE
$30.4B
| $504K | 0.08% |
9,691
| – | – |
|
|
SUNE
317
DELISTED
SUNEDISON, INC COM
SUNE
| $504K | 0.08% |
38,636
+2,593
| +7% | +$29.2K |
|
318
Jones Lang LaSalle
JLL
$16.7B
| $503K | 0.08% |
4,915
| – | – |
|
|
INFA
319
DELISTED
INFORMATICA CORP
INFA
| $502K | 0.08% |
12,097
| – | – |
|
320
Pultegroup
PHM
$24.6B
| $501K | 0.08% |
24,604
+2,800
| +13% | +$49.6K |
|
321
AB InBev
BUD
$156B
| $500K | 0.08% |
4,700
| – | – |
|
322
Alexandria Real Estate Equities
ARE
$8.27B
| $498K | 0.08% |
7,824
| – | – |
|
323
Mid-America Apartment Communities
MAA
$15.4B
| $498K | 0.08% |
+8,200
| New | +$513K |
|
324
SPX Corp
SPXC
$10.9B
| $494K | 0.07% |
19,700
-1,052
| -5% | -$24.2K |
|
325
AptarGroup
ATR
$8.47B
| $492K | 0.07% |
7,255
-197
| -3% | -$12.6K |
|
Similar funds
SV
LNWTC
VCM
ACM
JRP
MA
GIBU
EI
Shelton Capital Management's Q4 2013 Portfolio in Review
As of Q4 2013, Shelton Capital Management held 777 positions worth $661M, up 11% from $598M the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Shelton Capital Management's Q4 2013 filing shows 87 new, 152 increased, 160 reduced and 27 closed positions. Its largest new stake was Axos Financial: 63,596 shares worth $1.25M. The largest sale was BioMarin Pharmaceuticals, an estimated $3.57M.
By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.
- Shelton Capital Management's largest Q4 2013 buy was Axos Financial: 63,596 shares worth $1.25M.
- Shelton Capital Management added most to Tesla in Q4 2013, an estimated $1.09M increase.
- Shelton Capital Management's biggest Q4 2013 reduction was BioMarin Pharmaceuticals, cutting an estimated $3.57M.
- Shelton Capital Management fully exited Ametek in Q4 2013, selling an estimated $1.25M.
- Shelton Capital Management's ten largest holdings make up 17% of its $661M portfolio in Q4 2013.
- Shelton Capital Management opened 87 new positions and closed 27 in Q4 2013.
- Shelton Capital Management's portfolio value rose 11% quarter-over-quarter to $661M.
Based on Shelton Capital Management's 13F filing for Q4 2013, filed 22 Jan 2014.